Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease

Michael Ewers, Susanne Schmitz, Oskar Hansson, Cathal Walsh, Annette Fitzpatrick, David Bennett, Lennart Minthon, John Q. Trojanowski, Leslie M. Shaw, Yetunde O. Faluyi, Bruno Vellas, Bruno Dubois, Kaj Blennow, Katharina Buerger, Stefan J. Teipel, Michael Weiner, Harald Hampel

Research output: Contribution to journalArticlepeer-review

Abstract

Weight changes are common in aging and Alzheimer's disease (AD) and postmortem findings suggest a relation between lower body mass index (BMI) and increased AD brain pathology. In the current multicenter study, we tested whether lower BMI is associated with higher core AD brain pathology as assessed by cerebrospinal fluid (CSF)-based biological markers of AD in 751 living subjects: 308 patients with AD, 296 subjects with amnestic mild cognitive impairment (MCI), and 147 elderly healthy controls (HC). Based upon a priori cutoff values on CSF concentration of total tau and beta-amyloid (Aβ 1-42), subjects were binarized into a group with abnormal CSF biomarker signature (CSF+) and those without (CSF-). Results showed that BMI was significantly lower in the CSF+ when compared with the CSF- group (F = 27.7, df = 746, p < 0.001). There was no interaction between CSF signature and diagnosis or apolipoprotein E (ApoE) genotype. In conclusion, lower BMI is indicative of AD pathology as assessed with CSF-based biomarkers in demented and nondemented elderly subjects.

Original languageEnglish
Pages (from-to)1599-1608
Number of pages10
JournalNeurobiology of Aging
Volume33
Issue number8
DOIs
Publication statusPublished - Aug 2012
Externally publishedYes

Keywords

  • Alzheimer's disease
  • Body mass index
  • Cerebrospinal fluid
  • Tau protein

Fingerprint

Dive into the research topics of 'Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease'. Together they form a unique fingerprint.

Cite this